Merestinib on Bone Metastases in Subjects With Breast Cancer
Clinical trial NCT03292536 · TERMINATED
Trial details
- NCT number
- NCT03292536
- Sponsor
- University of Utah
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-11
- Primary completion
- 2019-06-24
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.